Cytovance to scale up mAb for Selexys’s Phase I trial
Cytovance will use both single-use and stainless steel in its monoclonal antibody (mAb) manufacturing deal with Selexys Pharmaceuticals.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs